文献速递临床生化质量管理与危急值

重叠置信区间在临床化学系列检验结果变化监测中的临床应用

Clinical Application of Overlapping Confidence Intervals for Monitoring Changes in Serial Clinical Chemistry Test Results.
PubMed 文献 · Ann Lab Med · 2020-01-01

该研究分析了临床化学实验室33个常规检测项目的1,202,096对配对结果,引入重叠置信区间(CI)概念判断系列检验结果变化是否具有统计学显著性。研究发现大多数分析物个体指数低、个体间变异大,各分析物第97.5百分位截止值远大于常规参考变化值(RCV),超过RCV95%和RCV99%的结果百分比分别对应83.4%和93.2%置信水平下的无重叠。结论认为重叠CI可克服现有RCV的局限性并取而代之,尤其适用于个体内变异大的分析物。

要点

  • 重叠置信区间可用于判断临床化学系列检验结果变化是否具有统计学显著性。
  • 各分析物第97.5百分位截止值远大于常规参考变化值。
  • 重叠CI尤其适用于个体内变异大的分析物,可替代RCV。

核心结论

  • 使用重叠置信区间监测临床化学系列检验结果变化可克服现有RCV的局限性并替代RCV,尤其适用于个体内变异大的分析物。

研究设计与样本

  • 研究分析了临床化学实验室33个常规检测项目的共1,202,096对配对结果。
  • 计算了delta%绝对值的分布及特定百分位的截止值,基于生物学变异设定各分析物的CI,并在不同置信水平下分析数据。
  • 同时使用RCV分析数据并比较其临床效用。

主要发现

  • 大多数分析物个体指数低,个体间变异大。
  • 各分析物第97.5百分位截止值远大于常规RCV。
  • 超过RCV95%和RCV99%的结果百分比分别对应83.4%和93.2%置信水平下的无重叠。

关键数值与推荐

  • 各分析物第97.5百分位截止值远大于常规RCV。
  • 超过RCV95%的结果百分比对应83.4%置信水平下的无重叠。
  • 超过RCV99%的结果百分比对应93.2%置信水平下的无重叠。

临床怎么用

  • 临床实验室可利用重叠置信区间判断系列临床化学检验结果变化是否具有统计学显著性。
  • 对于个体内变异大的分析物,重叠CI可作为RCV的替代方法。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Interpretation of changes in serial laboratory results is necessary for both clinicians and laboratories; however, setting decision limits is not easy. Although the reference change value (RCV) has been widely used for auto-verification, it has limitations in clinical settings. We introduce the concept of overlapping confidence intervals (CIs) to determine whether the changes are statistically significant in clinical chemistry laboratory test results. METHODS: In total, 1,202,096 paired results for 33 analytes routinely tested in our clinical chemistry laboratory were analyzed. The distributions of delta% absolute values and cut-off values for certain percentiles were calculated. The CIs for each analyte were set based on biological variation, and data were analyzed at various confidence levels. Additionally, we analyzed the data using RCVs and compared their clinical utility. RESULTS: Most analytes had low indexes of individuality with large inter-individual variability. The 97.5th percentile cut-offs for each analyte were much larger than conventional RCVs. The percentages of results exceeding RCV95% and RCV99% corresponded to those with no overlap at the 83.4% and 93.2% confidence levels, respectively. CONCLUSIONS: The use of overlapping CIs in serial clinical chemistry test results can overcome the limitations of existing RCVs and replace them, especially for analytes with large intra-individual variation.

来源:Ann Lab Med,查看原文。版权归原作者所有。

引用

  1. Cho J, Seo DM, Uh Y, et al. Clinical Application of Overlapping Confidence Intervals for Monitoring Changes in Serial Clinical Chemistry Test Results. Ann Lab Med. 2020. PMID: 31858759. doi:10.3343/alm.2020.40.3.201

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。